Objective: To investigate extended spectrum β- lactamase (ESBL) producing Klebsiella pneumoniae isolated from sputum of tuberculosis suspected patients in Basra governorate. Methods: A total of 28 (30.4 %) isolates of K. pneumoniae were recovered from 92 sputum clinical specimens at Pulmonary and Res...
While ESBLs rendered cephalosporin and aztreonam inactive • Chromosomal-mediated beta-lactamases (AmpC) are produced by indole-positive Proteus, Serratia, Morganella sp., and Citrobacter and are resistant to all beta-lactams except Carbapenems • Type of beta-lactamases: • There are various ...
For preliminary screening of ESBL producing P. aeruginosa, the susceptibility of the isolates was determined against third generation cephalosporins following the method of Kirby Bauer (1966)1 . These antibiotics are most commonly used to treat P. aeruginosa infections. ESBL positive isolates were ...
ESBLPoultryThe present study was conducted to detect the occurrence of beta-lactamase and biofilm-producing Escherchia coli and Salmonella in apparently healthy broiler birds reared in household and contract poultry farms. In total, 150 cloacal swabs were collected from apparently healthy broiler birds...
Most gram-positive bacteria are capable of producing and secreting beta-lactamase into the medium surrounding the organism. Thus, if the antibiotic is sensitive to the enzyme, drug inactivation will occur primarily extracellularly. On the other hand, gram-negative bacteria secrete less enzyme into th...
Survey of CTX-M-3 extended-spectrum b-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan Wu,L.,T.,... - 《Diagnostic Microbiology & Infectious Disease》 被引量: 27发表: 2004年 Prevalence of extended-spectrum beta-lactamase-producing Escherichia ...
2) Extend-spectrumβ-lactamase (ESBL) 超广谱β-内酰胺酶(ESBL) 3) extended 超广谱 1. The distribution and antibiotic susceptibility of producingextended-spectrum beta-lactamases(ESBLs)bacteria in Wuhan area in 2000; 2000年武汉地区产超广谱β-内酰胺酶菌种的分布及药敏分析 ...
Research conducted at Zainoel Abidin General Hospital in Banda Aceh between January 2022 and July 2023, focused on the prevalence and susceptibility patterns of extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli associated with nosocomial infections. This study employed a retrospective ...
Imipenem–relebactam and meropenem–vaborbactam are highly active against ESBL-producing Enterobacterales due to the intrinsic activity of carbapenems on these pathogens [43, 77]. Gram-positive bacteria and most of cultivable anaerobes are intrinsically resistant to ceftolozane–tazobactam, ceftazidime–...
Broad spectrum beta-lactamase inhibitors. Certain inhibitors also exhibit potent antibiotic activity in addition to beta-lactamase inhibition. Compounds of the invention are designed such that on cleavage of the beta-lactam ring reactive moieties are generated which can inactivate beta-lactamase. Also pro...